Jagsonpal Pharmaceuticals standalone net profit declines 28.74% in the June 2024 quarter

08 Aug 2024

Jagsonpal Pharmaceuticals standalone net profit declines 28.74% in the June 2024 quarter

Net profit of Jagsonpal Pharmaceuticals declined 28.74% to Rs 5.33 crore in the quarter ended June 2024 as against Rs 7.48 crore during the previous quarter ended June 2023. Sales rose 2.14% to Rs 61.44 crore in the quarter ended June 2024 as against Rs 60.15 crore during the previous quarter ended June 2023.

ParticularsQuarter Ended
Jun. 2024Jun. 2023% Var.
Sales61.4460.15 2
OPM %16.6814.35 -
PBDT11.4710.48 9
PBT10.4010.09 3
NP5.337.48 -29
Explore our products
₹0 Brokerage *
*By signing up you agree to our Terms and Conditions

Top Blogs

blog-article-image-one

Insights

Top Jewellery Stocks in India

13 mins read . Nov 19, 2024

blog-article-image-one

Insights

List of Stock Exchanges in India

16 mins read . Nov 19, 2024

blog-article-image-one

Economy

Hindustan Unilever History

14 mins read . Nov 8, 2024

future contract
Explore our products
₹0 Brokerage *
Open Demat Account